Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
MRVI moved a median of -0.18% 30 minutes after news, and -0.24% by the close. How MRVI actually reacts to news — the realized, point-in-time move the market made, measured across 1,201 labeled events over the last three years with zero look-ahead.
MRVI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 1,199 |
| 30-min | -0.18% | 44% | 1,201 |
| 60-min | +0.16% | 51% | 1,201 |
| to close | -0.24% | 46% | 1,193 |
| Middle 50% of MRVI reactions | -1.16% to +1.32% |
|---|---|
| Median reaction (30-min) | -0.18% |
| Measured reactions | 1,201 |
Half of all Maravai LifeSciences Holdings, Inc. - Class A common stock news events land between -1.16% and +1.32% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How MRVI reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 15 | +3.20% | 67% | +1.69% |
| Coverage initiations | 13 | -0.49% | 15% | -1.27% |
| Rating reiterations | 28 | +0.49% | 68% | +3.35% |
| Price-target cuts | 12 | +0.16% | 50% | +0.86% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how MRVI ranks against every other measured name →
That’s how MRVI usually reacts — get an email when it moves on news →Email me when MRVI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MRVI's baseline. Nothing else.
Recent MRVI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026 | Press release | Business Wire | -1.64% | +5.52% | |
| TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP | Press release | Business Wire | +0.13% | +0.13% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.31% | — | |
| Form 8-K MARAVAI LIFESCIENCES For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +3.13% | +14.73% | |
| Maravai LifeSciences Reports Second Quarter 2026 Financial Results | Press release | Business Wire | +3.13% | +14.73% | |
| Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 | Press release | Business Wire | +2.54% | -0.56% | |
| TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology | Press release | Business Wire | -0.14% | +2.90% | |
| TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale | Press release | Business Wire | +0.00% | +1.01% | |
| Form 8-K MARAVAI LIFESCIENCES For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | +0.20% | -1.43% | |
| Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032 | Press release | Business Wire | +0.20% | -1.43% | |
| Form 8-K MARAVAI LIFESCIENCES For: May 26 | SEC filing · Form 8-K | SEC EDGAR | -0.83% | -1.04% | |
| Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference | Press release | Business Wire | +0.99% | +4.20% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.45% | -2.07% | |
| Form 8-K MARAVAI LIFESCIENCES For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +4.82% | +11.24% | |
| Maravai LifeSciences Reports First Quarter 2026 Financial Results | Press release | Business Wire | +4.82% | +11.24% | |
| Form DEFA14A MARAVAI LIFESCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +1.37% | -2.47% | |
| Form ARS MARAVAI LIFESCIENCES For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | +3.96% | |
| Form DEF 14A MARAVAI LIFESCIENCES For: May 26 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +3.96% | |
| Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 | Press release | Business Wire | -1.79% | +1.38% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.35% | +0.87% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.34% | +1.55% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.35% | +0.35% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.70% | +0.35% | |
| Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.16% | -0.16% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.48% | -2.10% | |
| Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.16% | -1.27% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -2.24% | +0.64% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.14% | -4.64% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +4.57% | +3.71% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.14% | +3.07% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +2.28% | +2.85% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -0.42% | -0.14% | |
| Form 10-K MARAVAI LIFESCIENCES For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.85% | +0.85% | |
| Form 8-K MARAVAI LIFESCIENCES For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | +4.19% | -0.56% | |
| Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | Business Wire | +4.19% | -0.56% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | +5.30% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.84% | -1.35% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.17% | -0.49% | |
| Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 | Press release | Business Wire | +3.21% | +0.32% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.16% | -0.32% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.31% | -3.13% | |
| Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.58% | -4.82% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +2.09% | +0.60% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.13% | +0.66% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.14% | +0.27% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.25% | -3.89% | |
| Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -1.57% | -2.09% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.13% | +1.26% | |
| Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MRVI section they belong to.
Where else MRVI is measured.
MRVI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Maravai LifeSciences Holdings, Inc. - Class A common stock's median reaction calculated?
Every labeled MRVI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,201 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of MRVI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MRVI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.